Health CarePharmaceuticals & Biotechnology
  • Price (GBX)898.50
  • Today's Change2.00 / 0.22%
  • Shares traded11.65k
  • 1 Year change50.25%
  • Beta0.4157
Data delayed at least 20 minutes, as of Oct 24 2016 09:21 BST.
More ▼

Key statistics

As of last trade Abcam PLC (ABC:LSE) traded at 898.50, -0.77% below its 52-week high of 905.50, set on Oct 21, 2016.
52-week range
547.00Nov 23 2015905.50Oct 21 2016
Markit short selling activity
Previous close896.50
Average volume646.68k
Shares outstanding202.89m
Free float171.45m
P/E (TTM)48.38
Market cap1.82bn GBP
EPS (TTM)0.1853 GBP
Annual div (IAD)8.91 GBX
Annual div yield (IAD)0.99%
Div ex-dateMar 17 2016
Div pay-dateApr 15 2016
Next div ex-dateNov 10 2016
Next div pay-dateDec 02 2016
Data delayed at least 20 minutes, as of Oct 24 2016 09:21 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Abcam PLC shares was Buy at 792.00 on 12 Sep 2016Read the full article

Board of Directors


Murray Hennessy, MBA, Chairman


Alan Hirzel, BS MS MBA, Chief Executive Officer


Jeff Iliffe, BSc ACA, Chief Financial Officer and Company Secretary


Jim Warwick, MA (Cantab), Chief Operating Officer


Jonathan Milner, PhD, Deputy Chairman


Louise Patten, MA (Oxon), Non-executive and Senior Independent Director


Sue Harris, BSc ACMA, Non-executive Director


Anthony Martin, PhD, Non-executive Director


Michael Ross, MA (Cantab), Non-executive Director

Investor relations contacts and advisors

Corporate Headquarters:
Abcam plc
330 Cambridge Science Park
T: +44 (0)1223 696000
F: +44 (0)1223 215 215
Financial Advisors, Nominated Advisors and Joint Brokers:
J.P. Morgan Cazenove
25 Bank Street
Canary Wharf
London E14 5JP
T: + 44 (0) 20 7742 4000
Public Relations Advisors:
16 Lincoln’s Inn Fields
London WC2A 3ED
T: +44 (0)20 7404 5959
F: +44 (0)20 7831 2823
Joint Brokers:
Peel Hunt LLP
Moor House
120 London Wall
London EC2Y 5ET
T: +44 (0)207 418 8900
F: +44 (0)207 972 0112
Capita Registrars
Northern House
Woodsome Park
Fenay Bridge
Shareholder Help Line:
T: +44 (0)871 664 0300
(calls cost 10p per min plus network extras. Lines are open 8:30am-5:30pm Mon-Fri)
F: +44 (0)1484 600911
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.